RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Novartis
N

Novartis portfolio

Novartis has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Aktis Oncology's $84M Series A round in August 2022, alongside Vida Ventures, TCG Crossover, Pappas Capital and 6 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with TCG Crossover, MPM Capital and Vida Ventures, most often TCG Crossover (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $156M.
Latest deal: Aktis Oncology · Aug 26, 2022.

What Novartis invests in

How Novartis invests

StageDealsCapital in rounds
Series A 2 100%$156M
YearDealsCapital in rounds
2021 1 50%$72M
2022 1 50%$84M

Share is of the 2 rounds on Recent Funding that name Novartis. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Novartis portfolio companies

CompanyRound with NovartisTotal raisedLatest raise
AAktis Oncology
Health and bio
Series A · $84M$336MSep 1, 2024
Series B+
FFlare Therapeutics
Health and bio
backer$85MJun 30, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Novartis, which is a subset of its real portfolio. API: /api/v1/investors/novartis (get a free API key). More: the most active VC firms and new venture capital funds.